Cargando…
EMT-induced metabolite signature identifies poor clinical outcome
Metabolic reprogramming is a hallmark of cancer. Epithelial-mesenchymal transition (EMT) induces cancer stem cell (CSC) characteristics and promotes tumor invasiveness; however relatively little is known about the metabolic reprogramming in EMT. Here we show that breast epithelial cells undergo meta...
Autores principales: | Bhowmik, Salil Kumar, Ramirez-Peña, Esmeralda, Arnold, James Michael, Putluri, Vasanta, Sphyris, Nathalie, Michailidis, George, Putluri, Nagireddy, Ambs, Stefan, Sreekumar, Arun, Mani, Sendurai A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767460/ https://www.ncbi.nlm.nih.gov/pubmed/26315396 |
Ejemplares similares
-
Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance()()()
por: Putluri, Nagireddy, et al.
Publicado: (2014) -
Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors
por: Ballester, Leomar Y., et al.
Publicado: (2018) -
Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism
por: Yu, Wangie, et al.
Publicado: (2018) -
Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
por: Vantaku, Venkatrao, et al.
Publicado: (2017) -
Correction: Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
por: Vantaku, Venkatrao, et al.
Publicado: (2019)